In the News
November 21, 2019
Rochester cancer-therapy firm to collaborate with drugmaker on melanoma treatment
Star Tribune
November 6, 2019
Rochester biotech firm strikes ‘significant’ deal with drug maker
Rochester Post-Bulletin
January 17, 2019
State of the Art Cancer Therapeutics Manufacturing Headquarters Celebrates Grand Opening in Rochester Next Week
Rochester Rising
July 27, 2018
Vyriad Expands Phase 1 Trial to Test Voyager-V1 in Combination with Bevencio for Colorectal Cancer
Immuno-Oncology News
June 11, 2018
Mayo Clinic patient treated by massive measles dose still cancer-free 5 years later
Star Tribune
March 28, 2018
Mayo Clinic Biotech Spin-Off Vyriad Raising $9M for Expansion, Clinical Trials
Twin Cities Business